Veraxa Biotech Outlines FDA-Aligned Model Integration Into R&D Strategy
Veraxa Biotech AG detailed its integration of FDA-aligned New Approach Methodologies (NAMs) into its R&D strategy. The company stated this approach could accelerate its BiTAC® Oncology pipeline and significantly reduce animal testing.